[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

European Drug of Abuse Testing Market Reviewed by VPG in New Study Recently Published at MarketPublishers.com

30 Oct 2015 • by Natalie Aster

LONDON – The rapidly evolving market for drug of abuse (DOA) testing is expected to open up bright opportunities for a diversity of novel instruments, reagent systems, and auxiliary products, like controls, calibrators, devices used to prepare specimens, etc.

In the foreseeable future, the abused drug testing market is anticipated to undergo dramatic transformation, caused by convergence of novel and more stringent regulations; developments in diagnostic technologies, automation, IT, and system engineering; and the rising level of competition.

Abbott Laboratories, Biomedical Diagnostics, Wallac/PE, Tosoh, Roche, Quest Diagnostics, Kyowa Medex, DiaSorin, Eiken, AdnaGen/Alere, and Fujirebio, among others, are the major companies involved in the market. Among the strategies used by the players for penetrating the market one can name internal business development, collaborative agreements, university contracts, and distribution strategies for decentralized testing markets, among others. Meantime, technological advantages and limitations, regulatory constraints, patent protection, decentralized testing market challenges are amid potential risks and barriers to market entry.

In-demand report “2016 Europe Drugs of Abuse Testing Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers” elaborated by Venture Planning Group (VPG) draws up a detailed picture of the drugs of abuse testing market in the European region, with a special focus on the major countries such as Germany, France, Spain, Italy and the UK. The report presents test volume and sales forecasts, by market segment and country, for the assays such as antidepressants, barbiturates, amphetamines, benzodiazepines, cocaine, cannabinoids/marijuana, LSD, methadone, opiates, methaqualone, propoxyphene and phencyclidine (PCP). It provides also covers emerging tests, instrumentation, technologies, prospective trends, market shares, and the leading suppliers’ strategic profiles.

Report Details:

2016 Europe Drugs of Abuse Testing Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers
Published: October, 2015
Pages: 300
Price: US$ 6,500.00 

More studies by the publisher can be found at VPG page.


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected] 

Analytics & News

Weekly Digest